Feasibility of a pharmacist-led symptom monitoring and management intervention to improve breast cancer endocrine therapy adherence

MLA

Joan Neuner, et al. “Feasibility of a Pharmacist-Led Symptom Monitoring and Management Intervention to Improve Breast Cancer Endocrine Therapy Adherence.” Journal of the American Pharmacists Association, vol. 62, July 2022, p. 1321–1328.e3. EBSCOhost, https://doi.org/10.1016/j.japh.2022.03.001.

APA

Joan Neuner, Elizabeth Weil, Nicole Fergestrom, Melinda Stolley, Sailaja Kamaraju, Carolyn Oxencis, Aaron Winn, Purushottam W. Laud, & Kathryn E. Flynn. (2022). Feasibility of a pharmacist-led symptom monitoring and management intervention to improve breast cancer endocrine therapy adherence. Journal of the American Pharmacists Association, 62, 1321–1328.e3. https://doi.org/10.1016/j.japh.2022.03.001

Chicago

Joan Neuner, Elizabeth Weil, Nicole Fergestrom, Melinda Stolley, Sailaja Kamaraju, Carolyn Oxencis, Aaron Winn, Purushottam W. Laud, and Kathryn E. Flynn. 2022. “Feasibility of a Pharmacist-Led Symptom Monitoring and Management Intervention to Improve Breast Cancer Endocrine Therapy Adherence.” Journal of the American Pharmacists Association 62 (July): 1321–1328.e3. doi:10.1016/j.japh.2022.03.001.